about
Behaviour sequelae following acute Kawasaki diseaseCellular and molecular basis of RV hypertrophy in congenital heart diseaseKawasaki disease: an evidence based approach to diagnosis, treatment, and proposals for future researchOutcome following patent ductus arteriosus ligation in premature infants: a retrospective cohort analysis.Hypoplastic left heart syndrome: diagnosis and management.Kawasaki disease in children.Cardiac hydatid disease in the third world.Percutaneous retrieval of central venous catheter fragments.Spontaneous spasm of the arterial duct: a pitfall for transcatheter occlusion.Anomalous Left Coronary From the Pulmonary Artery Presenting as Ventricular Fibrillation After Persistent Ductus Arteriosus Ligation.Interventional cardiac catheterisation in congenital heart disease.The European Forum for Clinical Management: prophylaxis against the respiratory syncytial virus in infants and young children with congenital cardiac disease.Management and therapeutic options in pediatric pulmonary hypertension.Hypocalcaemia and vitamin D deficiency: an important, but preventable, cause of life-threatening infant heart failure.Treatment of pediatric pulmonary hypertensionManagement of pulmonary hypertension in Down syndrome.Evolving management of pediatric pulmonary arterial hypertension: impact of phosphodiesterase inhibitors.Prevention and prophylaxis of respiratory syncytial virus in pediatric cardiology: a UK perspective.Fifteen-minute consultation: rheumatic fever.Lung function in pulmonary hypertension.Sildenafil in Infants and ChildrenCHD and respiratory syncytial virus: global expert exchange recommendations.Early Experience of Macitentan for Pulmonary Arterial Hypertension in Adult Congenital Heart Disease.Comparison of the effect of inhaled anaesthetic with intravenous anaesthetic on pulmonary vascular resistance measurement during cardiac catheterisation.Successful introduction and audit of a step-down oral antibiotic strategy for low risk paediatric febrile neutropaenia in a UK, multicentre, shared care setting.Age no barrier to diagnosis.Transcatheter umbrella closure of aorto-pulmonary window.Antenatal diagnosis and postnatal treatment of intrapulmonary arteriovenous malformationCoil occlusion of systemic venous collaterals in hypoplastic left heart syndrome.Acute myocardial infarction as a cause of death in palliated hypoplastic left heart syndrome.The Perception of a Three-Dimensional-Printed Heart Model from the Perspective of Different Stakeholders: A Complex Case of Truncus ArteriosusRole of NO in recovery from neonatal hypoxic pulmonary hypertension.Polarized fibronectin secretion and localized matrix assembly sites correlate with subendothelial matrix formation.Echocardiographic screening in neonates undergoing surgery for selected gastrointestinal malformations.Pulmonary arterial hypertension exacerbated by ruxolitinib.Transient neonatal galactosaemia.Vancomycin and necrotising enterocolitis.The neonatal thymus and antenatal steroids.Fatal chickenpox: negative electron microscopy of vesicular samples may be misleading.Cardiac function and hemodynamics in Kenyan children with severe malaria.
P50
Q21260341-41CBD3A9-9BE6-46C5-B796-659477928523Q26777913-7D02D651-962C-4456-B496-EA91435BB628Q28192643-4C984A60-8A03-4752-B71F-F11FB9087762Q30814836-3931050B-D3F2-44AA-8E81-48ECEEEEE17AQ34518434-38886FAC-4EAE-4747-B0DF-19B2E31CECADQ34807614-994613AE-D5AC-4CE2-8160-DDEF5895B00FQ34815928-4EBA3617-ADCB-48AA-96E1-EEB100898A68Q35273043-BCFB5F32-8A70-4C54-8026-5BC2B2FD96B9Q35583455-BC3BD478-0110-47A6-833B-B834D2937C33Q35682237-EC186B2C-DDAC-4DBC-84C4-4803D5240C67Q35959079-3B860A0A-BF2F-47FE-9D3C-92F0C9186EAEQ36112926-FD9379D3-F49D-470A-8A19-E181D6453A79Q36484917-F78C7482-9BE2-4B03-A372-F36F8FF2A611Q36906523-DEF926FD-CA76-4E06-9EFA-74AFC89DF590Q37230469-A66BFBD8-AD7F-431F-B26C-B61EBC728677Q37825799-E7B47E3C-9584-4EF4-B6EA-33E2F2488709Q38068345-E6B27AF4-11B8-4233-9768-FD94D7C9A588Q38206841-4DAFE0C9-25E1-49B5-959F-4F0C48C4B005Q38344739-983A5800-7030-4FA8-A576-C3A2A13D7F36Q38512141-65A08A08-D8E7-4233-A086-BFDC95E3E570Q38652768-24314EB0-E55C-4762-9F06-340D7337AAC8Q38723728-7CA6681D-BD29-473E-A395-D54FB117739BQ38942104-CCA50634-BA76-4674-8ED2-D82C7F8B3AC8Q39248675-DD0C1233-DDD3-400E-8F5E-2C795FB876B0Q40384444-9888FA8F-DD8E-49EA-B0CA-B67C18500BC6Q40394102-FBE84C28-5E80-4954-877F-943DA10504DAQ41343313-86A548B1-1FDF-461F-8752-180D26731F4FQ41790352-B950F533-4403-4B7F-AFBF-033E17B2C391Q42009287-F8EC767F-4B86-4230-88B3-E76380B05CFEQ42184527-886F0120-DEDD-4C50-A0BC-444B94E6C21AQ42369881-6FEACBCA-F108-4618-9D9E-3EECDFA96477Q42476530-73AFCA9D-04C5-4FDD-9485-8DFF096535B4Q42481316-36BEF527-822E-405A-995E-0A3C9D904456Q42701603-3C10F273-A915-47BC-BEF4-E37D66E58D47Q42847687-4ECC1EC1-77C5-4D16-8DE9-6408E23C950AQ42992363-F8CD2C62-4A42-484F-B237-050179BB5743Q42997150-D2035955-686A-44C5-B281-D38D6CD745A6Q43097912-0BB23AF6-AD32-47FB-A002-566A8234CDC0Q43102003-8B6E0162-7907-49FC-B4E3-3CDFACB54E08Q43196084-B8C5190A-F11C-41DA-98DB-0ECC1740CDFD
P50
description
hulumtues
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Robert M. Tulloh
@ast
Robert M. Tulloh
@en
Robert M. Tulloh
@es
Robert M. Tulloh
@sl
type
label
Robert M. Tulloh
@ast
Robert M. Tulloh
@en
Robert M. Tulloh
@es
Robert M. Tulloh
@sl
prefLabel
Robert M. Tulloh
@ast
Robert M. Tulloh
@en
Robert M. Tulloh
@es
Robert M. Tulloh
@sl
P1153
P106
P1153
55902305800
56167946100
56671008500
P21
P31
P496
0000-0002-3180-6993